1. Allen J.G., Havas L., Leicht E., Lenox-Smith I. and Nisbet L.J. (1979) Phosphonopeptides as antibacterial agents: Metabolism and pharmacokinetics of alafosfalin in animals and humans. Antimicrob. Agents Chemother. 16, 306–313.
2. Allen M., McMartin,C., Peters G.E. and Wade R. (1984) The mechanism of degradation Cyclo(Asn-Phe-Phe-D-Trp-LysThr-Phe-GABA) and the relative stabilities of this and other octapeptide Somatostatin analogs in rat. Regul. Pept. 10, 29–35.
3. Bajusz S., Patthy A., Kenessey A., Graf L., Szekely J.I. and Ronai A.Z. (1978) Is there correlation between analgesic potency and biodegradation of enkephalin analogs. Biochem. Biophys. Res. Commun. 84, 1045–1053.
4. Baker J.R.J., Kemmenoe B.H., McMartin.C. and Peters G.E. (1984) Pharmacokinetics, distribution and elimination of a synthetic octapeptide analog of somatostatin in rat. Regul. Pept. 9, 213–226.
5. Banting F.G. and Best C.H. (1922) The internal secretion of the pancreas. J. Lab. Clin. Med. 7, 251–266.